Benign symptomatic premature ventricular complexes: short- and long-term efficacy of antiarrhythmic drugs and radiofrequency ablation.
Sebastian Stec, Agnieszka Sikorska, Beata Zaborska...
https://pubmed.ncbi.nlm.nih.gov/22528707Actively Recruiting
Led by Centre of Postgraduate Medical Education · Updated on 2025-05-13
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are studying ventricular arrhythmias (VA) that originate at the base of the heart, focusing on cases where the standard unipolar radio-frequency (RF) ablation treatment fails. This study aims to find out how many patients need a follow-up procedure using bipolar RF ablation, which may be more effective for difficult-to-reach arrhythmias. They also want to identify electrophysiological signals that predict success or failure of these ablation methods and assess how these treatments affect patients’ quality of life. The study involves patients who have already undergone unipolar ablation for VA but may require further treatment. If unipolar ablation does not succeed, patients may receive bipolar ablation, which uses two electrodes to deliver RF energy between adjacent heart structures for deeper tissue treatment. The procedures use advanced mapping and catheter systems to guide ablation. Patients are monitored during the procedures, and coronary angiography is performed to ensure safety. Both unipolar and bipolar ablations are evaluated for their immediate and one-month effectiveness. Participants will have detailed heart studies and electrophysiological tests to guide treatment. They will be assessed before and after ablation with Holter ECG monitoring and quality of life questionnaires. Researchers are measuring the need for bipolar ablation after failed unipolar treatment, how well specific heart signals predict success, and the impact of ablation on symptoms and life quality over two years. Follow-up includes clinical evaluations and tests to track arrhythmia recurrence and treatment outcomes.
CONDITIONS
Bipolar Radio-frequency Ablation After Standard Unipolar Approach - Prospective Registry.
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Initial unipolar ablation procedure followed by bipolar ablation if needed; medium-term assessment at 1 month after each ablation
Participants undergo initial unipolar ablation to treat ventricular arrhythmias originating from the base of the heart. If unipolar ablation fails, bipolar ablation is performed as a redo procedure using two ablation catheters positioned in adjacent heart structures.
1 initial ablation visit and 1 follow-up visit at 1 month; additional ablation visit if bipolar ablation is required
Duration - Up to 2 years
Participants are followed up to assess medium-term efficacy of ablation procedures and quality of life changes using questionnaires before and 1 month after ablation.
Periodic assessments including 24-hour Holter ECG and quality of life questionnaires before and 1 month after ablation; additional follow-up visits as needed for monitoring
Total: 1 location
1
Department of Cardiology, Postgraduate Medical School, Grochowski Hospital
Warsaw, Poland, 04-073
Actively Recruiting
P
Piotr Kulakowski, MD PhD
A
Agnieszka Sikorska, MD PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Sebastian Stec, Agnieszka Sikorska, Beata Zaborska...
https://pubmed.ncbi.nlm.nih.gov/22528707Takumi Yamada, Naoki Yoshida, Harish Doppalapudi...
https://pubmed.ncbi.nlm.nih.gov/28500177Victor Neira, Pasquale Santangeli, Piotr Futyma...
https://pubmed.ncbi.nlm.nih.gov/32087355Jacob S Koruth, Srinivas Dukkipati, Marc A Miller...
https://pubmed.ncbi.nlm.nih.gov/22863684Peter J Sauer, Megan J Kunkel, Duy T Nguyen...
https://pubmed.ncbi.nlm.nih.gov/30820408Piotr Futyma, Pasquale Santangeli, Helmut Pürerfellner...
https://pubmed.ncbi.nlm.nih.gov/32348845Piotr Futyma, Jarosław Sander, Kamil Ciąpała...
https://pubmed.ncbi.nlm.nih.gov/31402415Paolo Della Bella, Giovanni Peretto, Gabriele Paglino...
https://pubmed.ncbi.nlm.nih.gov/32599177Miyako Igarashi, Akihiko Nogami, Seiji Fukamizu...
https://pubmed.ncbi.nlm.nih.gov/32353585Shinwan Kany, Fares Alexander Alken, Ruben Schleberger...
https://pubmed.ncbi.nlm.nih.gov/34922350